Solaris Pharma Corporation

Solaris Pharma Corporation company information, Employees & Contact Information

Solaris Pharma Corporation was founded in 2014 with the vision of improving the patients’ quality of life through development of niche pharmaceutical products. Located in Bridgewater, New Jersey, Solaris Pharma Corporation has a fully equipped Research & Development facility with expertise in the development of generic and specialty products. Solaris Pharma Corporation is uniquely poised to develop specialty dermatology products that have a relatively high barrier to entry due to manufacturing complexities and high-end clinical patient study demands. With a thorough knowledge of the development life cycle and well-trained, committed scientific personnel, Solaris Pharma Corporation has streamlined processes that are efficient in reducing development costs and shortening timelines, without compromise in quality. Solaris Pharma Corporation is currently engaged in the development of several generic dermatology products and is committed to establish itself as a pacesetter in dermatology pharmaceuticals.

Company Details

Employees
28
Founded
-
Address
1031 Us 202/206,
Phone
(908)720-2617
Email
In****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Bridgewater, New Jersey
Looking for a particular Solaris Pharma Corporation employee's phone or email?

Solaris Pharma Corporation Questions

News

Cardinal Health builds out urology focus with $1.9B deal for Solaris Health - Fierce Healthcare

Cardinal Health builds out urology focus with $1.9B deal for Solaris Health Fierce Healthcare

Medincell wins milestone from Teva on back of SOLARIS trial - The Pharma Letter

Medincell wins milestone from Teva on back of SOLARIS trial The Pharma Letter

Solaris Pharma Receives FDA Approval for Generic Metrogel-Vaginal® - GlobeNewswire

Solaris Pharma Receives FDA Approval for Generic Metrogel-Vaginal® GlobeNewswire

Bridgewater becomes home to another pharmaceutical company - Central New Jersey News

Bridgewater becomes home to another pharmaceutical company Central New Jersey News

First Generic Version of Clindagel Gets FDA Approval - Medical Professionals Reference

First Generic Version of Clindagel Gets FDA Approval Medical Professionals Reference

Solaris Pharma Receives Approval for First Generic Version of Clindagel® (clindamycin phosphate EQ 1%) - GlobeNewswire

Solaris Pharma Receives Approval for First Generic Version of Clindagel® (clindamycin phosphate EQ 1%) GlobeNewswire

Madison Street Capital Co-Advises Therachem Research Medilab (TRM) and Solaris Pharmachem For A Total Consideration of USD$75M Sale To PI Health Sciences Ltd. (PIHS) - PR Newswire

Madison Street Capital Co-Advises Therachem Research Medilab (TRM) and Solaris Pharmachem For A Total Consideration of USD$75M Sale To PI Health Sciences Ltd. (PIHS) PR Newswire

AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan - Fierce Pharma

AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan Fierce Pharma

Physician Views Preview: Can Teva’s formulation surmount the hurdles that tripped up other olanzapine versions for schizophrenia? - FirstWord Pharma

Physician Views Preview: Can Teva’s formulation surmount the hurdles that tripped up other olanzapine versions for schizophrenia? FirstWord Pharma

FDA approves first interchangeable biosimilar for Soliris - TechTarget

FDA approves first interchangeable biosimilar for Soliris TechTarget

Solaris Biotech: “We are Deeply Passionate About the Alternative Protein Sector and its Transformative Potential” - vegconomist

Solaris Biotech: “We are Deeply Passionate About the Alternative Protein Sector and its Transformative Potential” vegconomist

Uzedy partners Teva and MedinCell's latest long-acting schizophrenia candidate notches phase 3 win - Fierce Pharma

Uzedy partners Teva and MedinCell's latest long-acting schizophrenia candidate notches phase 3 win Fierce Pharma

Bridgewater OKs redevelopment of Sanofi site - Central New Jersey News

Bridgewater OKs redevelopment of Sanofi site Central New Jersey News

Amgen grabs FDA thumbs-up for Soliris biosim, eyes 2025 launch - Fierce Pharma

Amgen grabs FDA thumbs-up for Soliris biosim, eyes 2025 launch Fierce Pharma

AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says - Fierce Pharma

AstraZeneca's newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says Fierce Pharma

Top Solaris Pharma Corporation Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant